| Trial ID: | L3623 |
| Source ID: | NCT00543595
|
| Associated Drug: |
Mk0916
|
| Title: |
MK0916 in Patients With Type 2 Diabetes and Metabolic Syndrome (0916-005)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2|Metabolic Syndrome
|
| Interventions: |
DRUG: MK0916
|
| Outcome Measures: |
|
| Sponsor/Collaborators: |
Sponsor: Merck Sharp & Dohme LLC
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
154
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2004-08
|
| Completion Date: |
2005-05
|
| Results First Posted: |
|
| Last Update Posted: |
2015-05-22
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00543595
|
